[HTML][HTML] Chronic wound healing: a review of current management and treatments

G Han, R Ceilley - Advances in therapy, 2017 - Springer
Wound healing is a complex, highly regulated process that is critical in maintaining the
barrier function of skin. With numerous disease processes, the cascade of events involved in …

[HTML][HTML] Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection

LR Martinez, G Han, M Chacko, MR Mihu… - Journal of Investigative …, 2009 - Elsevier
Staphylococcus aureus (SA) is a leading cause of both superficial and invasive infections in
community and hospital settings, frequently resulting in chronic refractory disease. It is …

Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites

AJ Friedman, G Han, MS Navati, M Chacko, L Gunther… - Nitric oxide, 2008 - Elsevier
A new platform using biocompatible materials is presented for generating powders comprised
of nanoparticles that release therapeutic levels of nitric oxide (NO) in a controlled and …

[HTML][HTML] Nitric oxide–releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition

G Han, LN Nguyen, C Macherla, Y Chi… - The American journal of …, 2012 - Elsevier
Wound healing is a complex process that involves coordinated interactions between diverse
immunological and biological systems. Long-term wounds remain a challenging clinical …

Baricitinib in patients with moderate-to-severe atopic dermatitis: results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

…, JI Silverberg, M Zirwas, E Maverakis, G Han… - Journal of the American …, 2021 - Elsevier
… Dr Han is a consultant for Eli Lilly and Company, Regeneron, Sanofi, and Pfizer. Dr
Guttman-Yassky is a consultant for AbbVie, Almirall, Amgen, Asana Biosciences, Boehringer …

Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model

…, MR Mihu, M Tar, RJB Cordero, G Han… - The Journal of …, 2010 - academic.oup.com
Candida species are a major cause of catheter infections. Using a central venous catheter
Candida albicans biofilm model, we demonstrated that chitosan, a polymer isolated from …

[HTML][HTML] Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection

G Han, LR Martinez, MR Mihu, AJ Friedman… - PloS one, 2009 - journals.plos.org
Staphylococcus aureus (SA) is a leading cause of a diverse spectrum of bacterial diseases,
including abscesses. Nitric oxide (NO) is a critical component of the natural host defense …

First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

…, GI Gutkin, M Haddix, AJ Hall, G Han… - MedRxiv, 2020 - medrxiv.org
Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been reported
worldwide. We describe the epidemiology, clinical course, and virologic characteristics of …

High-frequency, high-throughput quantification of SARS-CoV-2 RNA in wastewater settled solids at eight publicly owned treatment works in Northern California shows …

…, DJ Vugia, AT Yu, L Li, M Balliet, P Stoddard, GS Han… - Msystems, 2021 - Am Soc Microbiol
A number of recent retrospective studies have demonstrated that severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) RNA concentrations in wastewater are associated …

The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections

MR Mihu, U Sandkovsky, G Han, JM Friedman… - Virulence, 2010 - Taylor & Francis
Acinetobacter baumannii (Ab) is a frequent cause of hospital acquired pneumonia and recently
has increased in incidence as the causative agent of severe disease in troops wounded …